Arianne Theiss
Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 15 | 2020 | 427 | 4.010 |
Why?
| | Colitis | 11 | 2022 | 266 | 3.760 |
Why?
| | Mitochondria | 13 | 2025 | 948 | 3.690 |
Why?
| | Inflammatory Bowel Diseases | 13 | 2025 | 351 | 3.360 |
Why?
| | Intestinal Mucosa | 19 | 2025 | 623 | 2.540 |
Why?
| | Crohn Disease | 5 | 2023 | 243 | 1.950 |
Why?
| | Paneth Cells | 4 | 2023 | 16 | 1.870 |
Why?
| | Colon | 10 | 2025 | 282 | 1.730 |
Why?
| | STAT3 Transcription Factor | 6 | 2015 | 206 | 1.500 |
Why?
| | Ileitis | 2 | 2023 | 32 | 1.470 |
Why?
| | Colorectal Neoplasms | 4 | 2024 | 806 | 1.200 |
Why?
| | Benzofurans | 2 | 2020 | 21 | 1.160 |
Why?
| | Gastrointestinal Microbiome | 4 | 2024 | 697 | 1.050 |
Why?
| | Inflammation | 11 | 2023 | 2837 | 1.000 |
Why?
| | Caco-2 Cells | 12 | 2018 | 77 | 0.990 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 146 | 0.990 |
Why?
| | Gastrointestinal Diseases | 2 | 2025 | 209 | 0.940 |
Why?
| | Colonic Neoplasms | 4 | 2021 | 258 | 0.920 |
Why?
| | Intestines | 6 | 2023 | 357 | 0.910 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2021 | 1396 | 0.910 |
Why?
| | Axin Protein | 2 | 2020 | 19 | 0.850 |
Why?
| | Epithelial Cells | 6 | 2016 | 1096 | 0.850 |
Why?
| | Mitochondrial Membranes | 1 | 2023 | 39 | 0.790 |
Why?
| | Inflammasomes | 2 | 2021 | 131 | 0.790 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2021 | 1242 | 0.780 |
Why?
| | beta Catenin | 2 | 2025 | 253 | 0.780 |
Why?
| | Antioxidants | 2 | 2021 | 584 | 0.780 |
Why?
| | Autophagy | 4 | 2023 | 284 | 0.750 |
Why?
| | Fatty Acids | 1 | 2025 | 443 | 0.740 |
Why?
| | Mice | 28 | 2025 | 17787 | 0.730 |
Why?
| | Apoptosis | 6 | 2020 | 2553 | 0.690 |
Why?
| | Intestinal Neoplasms | 1 | 2020 | 29 | 0.680 |
Why?
| | Adipose Tissue | 1 | 2025 | 635 | 0.680 |
Why?
| | Stem Cells | 1 | 2025 | 594 | 0.680 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 151 | 0.650 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.640 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5757 | 0.630 |
Why?
| | Carcinogenesis | 1 | 2020 | 217 | 0.600 |
Why?
| | Animals | 33 | 2025 | 36940 | 0.600 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.580 |
Why?
| | Glutarates | 1 | 2018 | 10 | 0.570 |
Why?
| | Cell Nucleus | 1 | 2020 | 620 | 0.540 |
Why?
| | Interleukin-17 | 4 | 2022 | 119 | 0.510 |
Why?
| | Obesity | 2 | 2025 | 2992 | 0.500 |
Why?
| | Dextran Sulfate | 5 | 2018 | 83 | 0.470 |
Why?
| | Colitis, Ulcerative | 4 | 2021 | 136 | 0.460 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2023 | 175 | 0.450 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2015 | 528 | 0.440 |
Why?
| | Signal Transduction | 4 | 2024 | 5079 | 0.430 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2022 | 14 | 0.430 |
Why?
| | Reactive Oxygen Species | 4 | 2023 | 622 | 0.420 |
Why?
| | NF-E2 Transcription Factor, p45 Subunit | 1 | 2013 | 3 | 0.410 |
Why?
| | Oxidative Stress | 3 | 2011 | 1317 | 0.410 |
Why?
| | Biological Products | 1 | 2016 | 216 | 0.390 |
Why?
| | Humans | 38 | 2025 | 137585 | 0.380 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 411 | 0.360 |
Why?
| | Mice, Transgenic | 6 | 2020 | 2167 | 0.340 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4295 | 0.330 |
Why?
| | alpha Karyopherins | 1 | 2009 | 11 | 0.320 |
Why?
| | Mice, Knockout | 7 | 2020 | 3015 | 0.310 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 87 | 0.310 |
Why?
| | Stress, Physiological | 1 | 2012 | 443 | 0.290 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2005 | 319 | 0.290 |
Why?
| | Interleukin-6 | 3 | 2007 | 778 | 0.290 |
Why?
| | Nanoparticles | 2 | 2011 | 481 | 0.280 |
Why?
| | Biopsy | 3 | 2021 | 1129 | 0.270 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 365 | 0.270 |
Why?
| | Collagen | 2 | 2005 | 452 | 0.250 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 26 | 0.240 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 43 | 0.240 |
Why?
| | Growth Hormone | 1 | 2005 | 101 | 0.230 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2025 | 38 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 152 | 0.230 |
Why?
| | Antineoplastic Agents | 2 | 2014 | 2129 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 185 | 0.220 |
Why?
| | Human Growth Hormone | 1 | 2004 | 48 | 0.220 |
Why?
| | Cell Proliferation | 3 | 2020 | 2475 | 0.220 |
Why?
| | Diet, High-Fat | 1 | 2025 | 247 | 0.210 |
Why?
| | Fibroblasts | 2 | 2005 | 996 | 0.210 |
Why?
| | Butyrates | 1 | 2023 | 61 | 0.200 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2607 | 0.200 |
Why?
| | p21-Activated Kinases | 1 | 2022 | 15 | 0.200 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 195 | 0.200 |
Why?
| | Up-Regulation | 2 | 2021 | 843 | 0.190 |
Why?
| | Cell Survival | 2 | 2018 | 1120 | 0.180 |
Why?
| | Enterocytes | 1 | 2021 | 16 | 0.180 |
Why?
| | RNA, Small Interfering | 3 | 2017 | 622 | 0.180 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1060 | 0.180 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2021 | 13 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 12 | 0.170 |
Why?
| | Genes, Reporter | 2 | 2013 | 269 | 0.170 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2020 | 3 | 0.170 |
Why?
| | Gene Silencing | 2 | 2012 | 195 | 0.170 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 257 | 0.170 |
Why?
| | Enterocolitis | 1 | 2020 | 17 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 327 | 0.170 |
Why?
| | Immunity, Innate | 2 | 2023 | 828 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 313 | 0.160 |
Why?
| | Transcription Factors | 2 | 2025 | 1719 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 955 | 0.160 |
Why?
| | Organoids | 1 | 2020 | 112 | 0.150 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 78 | 0.150 |
Why?
| | Homeostasis | 1 | 2023 | 621 | 0.150 |
Why?
| | Male | 10 | 2025 | 67762 | 0.150 |
Why?
| | Interleukin-18 | 1 | 2020 | 236 | 0.150 |
Why?
| | Piperidines | 1 | 2020 | 206 | 0.140 |
Why?
| | Immunity, Mucosal | 1 | 2019 | 97 | 0.140 |
Why?
| | Azoxymethane | 1 | 2018 | 20 | 0.140 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 385 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 430 | 0.140 |
Why?
| | Intercellular Adhesion Molecule-3 | 1 | 2017 | 2 | 0.140 |
Why?
| | Lipid Metabolism | 1 | 2021 | 518 | 0.140 |
Why?
| | LIM Domain Proteins | 1 | 2017 | 21 | 0.140 |
Why?
| | Curcuma | 1 | 2017 | 1 | 0.140 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 39 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1502 | 0.140 |
Why?
| | Oils, Volatile | 1 | 2017 | 6 | 0.140 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 52 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 2 | 2010 | 665 | 0.130 |
Why?
| | Blotting, Western | 2 | 2013 | 1226 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2017 | 2833 | 0.130 |
Why?
| | Green Fluorescent Proteins | 2 | 2010 | 390 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2531 | 0.130 |
Why?
| | Cytokines | 3 | 2017 | 2085 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2023 | 1164 | 0.130 |
Why?
| | Fibrosis | 3 | 2017 | 552 | 0.130 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 1250 | 0.120 |
Why?
| | Glutathione | 2 | 2009 | 356 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 278 | 0.120 |
Why?
| | Myofibroblasts | 1 | 2017 | 127 | 0.120 |
Why?
| | Ubiquitination | 3 | 2022 | 102 | 0.120 |
Why?
| | Neoplasms | 1 | 2011 | 2671 | 0.120 |
Why?
| | DNA Methylation | 1 | 2021 | 643 | 0.120 |
Why?
| | Oncogene Protein p21(ras) | 1 | 2015 | 16 | 0.120 |
Why?
| | Cells, Cultured | 2 | 2014 | 4193 | 0.120 |
Why?
| | Biological Assay | 1 | 2016 | 124 | 0.120 |
Why?
| | Risk | 1 | 2018 | 912 | 0.120 |
Why?
| | Phosphorylation | 2 | 2022 | 1759 | 0.110 |
Why?
| | Gene Knockdown Techniques | 2 | 2015 | 327 | 0.110 |
Why?
| | NF-kappa B | 2 | 2010 | 691 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 455 | 0.110 |
Why?
| | Interleukin-10 | 2 | 2006 | 302 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1112 | 0.100 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 7 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2017 | 496 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 967 | 0.100 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 32 | 0.100 |
Why?
| | Female | 8 | 2020 | 73304 | 0.100 |
Why?
| | Barrett Esophagus | 1 | 2015 | 149 | 0.100 |
Why?
| | RNA | 2 | 2013 | 921 | 0.100 |
Why?
| | Heme Oxygenase-1 | 1 | 2013 | 64 | 0.100 |
Why?
| | Luciferases | 1 | 2013 | 150 | 0.100 |
Why?
| | Inflammation Mediators | 1 | 2016 | 513 | 0.100 |
Why?
| | Phenotype | 1 | 2021 | 3196 | 0.100 |
Why?
| | Protein Binding | 2 | 2020 | 2224 | 0.100 |
Why?
| | Peroxidase | 1 | 2013 | 175 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.090 |
Why?
| | HCT116 Cells | 1 | 2012 | 80 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2012 | 72 | 0.090 |
Why?
| | Free Radical Scavengers | 1 | 2012 | 88 | 0.090 |
Why?
| | Intracellular Space | 1 | 2012 | 68 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2012 | 145 | 0.090 |
Why?
| | Polyethyleneimine | 1 | 2011 | 18 | 0.090 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 320 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1276 | 0.090 |
Why?
| | Time Factors | 4 | 2017 | 6828 | 0.090 |
Why?
| | DNA | 2 | 2009 | 1459 | 0.080 |
Why?
| | Th17 Cells | 2 | 2021 | 108 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 298 | 0.080 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.080 |
Why?
| | Adenocarcinoma | 2 | 2009 | 940 | 0.080 |
Why?
| | Protein Carbonylation | 1 | 2009 | 54 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 124 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2009 | 93 | 0.070 |
Why?
| | Gene Expression | 2 | 2020 | 1502 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 445 | 0.070 |
Why?
| | Acute Disease | 1 | 2010 | 1007 | 0.070 |
Why?
| | Salmonella typhimurium | 1 | 2009 | 183 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2847 | 0.070 |
Why?
| | Keratin-8 | 1 | 2007 | 4 | 0.070 |
Why?
| | Transcription Initiation Site | 1 | 2007 | 43 | 0.070 |
Why?
| | Transfection | 1 | 2009 | 945 | 0.060 |
Why?
| | Response Elements | 1 | 2007 | 91 | 0.060 |
Why?
| | Glutathione Transferase | 1 | 2006 | 106 | 0.060 |
Why?
| | Keratins | 1 | 2007 | 173 | 0.060 |
Why?
| | Prognosis | 1 | 2014 | 4030 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 9 | 0.060 |
Why?
| | Cecum | 1 | 2005 | 33 | 0.060 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 56 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2005 | 60 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2005 | 201 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 21 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2005 | 114 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2005 | 92 | 0.060 |
Why?
| | Homozygote | 1 | 2005 | 203 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2006 | 328 | 0.060 |
Why?
| | Polysaccharides | 1 | 2005 | 79 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2005 | 164 | 0.060 |
Why?
| | Granuloma | 1 | 2005 | 92 | 0.060 |
Why?
| | Joints | 1 | 2005 | 105 | 0.060 |
Why?
| | Protein Isoforms | 1 | 2005 | 404 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2005 | 810 | 0.050 |
Why?
| | Models, Biological | 1 | 2011 | 1783 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 378 | 0.050 |
Why?
| | Drug Interactions | 1 | 2004 | 410 | 0.050 |
Why?
| | Escherichia coli | 1 | 2007 | 815 | 0.050 |
Why?
| | Perylene | 1 | 2002 | 9 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2139 | 0.050 |
Why?
| | Photosensitizing Agents | 1 | 2002 | 41 | 0.050 |
Why?
| | Photochemotherapy | 1 | 2002 | 44 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2900 | 0.050 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 39 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2057 | 0.040 |
Why?
| | Citrobacter rodentium | 1 | 2020 | 7 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2021 | 257 | 0.040 |
Why?
| | Genotype | 1 | 2005 | 1916 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 2020 | 43 | 0.040 |
Why?
| | Chronic Disease | 1 | 2005 | 1793 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1457 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 465 | 0.040 |
Why?
| | Esophageal Neoplasms | 1 | 2002 | 321 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 210 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 549 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 789 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2828 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 683 | 0.030 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 327 | 0.030 |
Why?
| | Curcumin | 1 | 2017 | 29 | 0.030 |
Why?
| | Permeability | 2 | 2007 | 161 | 0.030 |
Why?
| | Collagen Type I | 1 | 2017 | 136 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 674 | 0.030 |
Why?
| | Rats | 1 | 2005 | 5647 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 191 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 145 | 0.030 |
Why?
| | Actins | 1 | 2017 | 416 | 0.030 |
Why?
| | Colonoscopy | 1 | 2017 | 245 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 730 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 900 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1991 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Computer Simulation | 1 | 2016 | 978 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 356 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5131 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3958 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 325 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7635 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 321 | 0.010 |
Why?
| | Aminolevulinic Acid | 1 | 2002 | 4 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1547 | 0.010 |
Why?
| | Anthracenes | 1 | 2002 | 31 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2002 | 141 | 0.010 |
Why?
| | Middle Aged | 2 | 2017 | 33479 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2007 | 3556 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 15657 | 0.010 |
Why?
| | Aged | 1 | 2017 | 23961 | 0.010 |
Why?
| | Adult | 1 | 2017 | 37929 | 0.010 |
Why?
|
|
Theiss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|